| Literature DB >> 36253398 |
Holly T Philpott1,2, Trevor B Birmingham1,2, Benoit Fiset3, Logan A Walsh3,4, Mitchell C Coleman5,6, Cheryle A Séguin2,7, C Thomas Appleton8,9,10,11.
Abstract
Synovium is critical for maintaining joint homeostasis and may contribute to mechanobiological responses during joint movement. We investigated mechanobiological responses of whole synovium from patients with late-stage knee osteoarthritis (OA). Synovium samples were collected during total knee arthroplasty and assigned to histopathology or cyclic 10% tensile strain loading, including (1) static (control); (2) low-frequency (0.3 Hz); and iii) high-frequency (1.0 Hz) for 30-min. After 6-h incubation, tissues were bisected for RNA isolation and immunostaining (3-nitrotyrosine; 3-NT). RNA sequencing was analyzed for differentially expressed genes and pathway enrichment. Cytokines and lactate were measured in conditioned media. Compared to controls, low-frequency strain induced enrichment of pathways related to interferon response, Fc-receptor signaling, and cell metabolism. High-frequency strain induced enrichment of pathways related to NOD-like receptor signaling, high metabolic demand, and redox signaling/stress. Metabolic and redox cell stress was confirmed by increased release of lactate into conditioned media and increased 3-NT formation in the synovial lining. Late-stage OA synovial tissue responses to tensile strain include frequency-dependent increases in inflammatory signaling, metabolism, and redox biology. Based on these findings, we speculate that some synovial mechanobiological responses to strain may be beneficial, but OA likely disturbs synovial homeostasis leading to aberrant responses to mechanical stimuli, which requires further validation.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36253398 PMCID: PMC9576717 DOI: 10.1038/s41598-022-22459-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Patient demographics, clinical characteristics and synovial histopathology.
| Characteristic | All patients (n = 10) | RNA sequencing sub-group (n = 6) |
|---|---|---|
| Age, years | 67.4 ± 7.9 [54–77] | 66.3 ± 9.5 [54–77] |
| Female | 4 (40.0%) | 2 (33.3%) |
| Male | 6 (60.0%) | 4 (66.7%) |
| BMI, (kg/m2) | 35.5 ± 6.1 [29.5–45.4] | 36.1 ± 5.6 [29.5–44.6] |
| Grade 3 | 3 (30.0%) | 1 (16.7%) |
| Grade 4 | 7 (70.0%) | 5 (83.3%) |
| KOOS Pain subscale, (0–100) | 39.6 ± 22.2 [0–67] | 39.5 ± 24.5 [0–67] |
| Synovial Lining thickness | 0.7 ± 0.4 [0.4–1.6] | 0.6 ± 0.4 [0.4–1.0] |
| Sub-synovial infiltrate | 1.2 ± 0.7 [0.6–2.4] | 1.3 ± 0.6 [0.6–2.2] |
| Fibrin Deposition | 0.8 ± 0.3 [0–1] | 0.8 ± 0.4 [0–1] |
| Vascularization | 1.8 ± 0.9 [0–3.0] | 1.7 ± 1.2 [0–3.0] |
| Fibrosis | 1.3 ± 0.6 [0.6–2.5] | 1.4 ± 0.5 [0.6–2.5] |
| Perivascular edema | 0.7 ± 0.6 [0–1.6] | 0.8 ± 0.8 [0–1.6] |
| Hypertension | 8 (80.0%) | 4 (66.7%) |
| Dyslipidemia | 6 (60.0%) | 3 (50.0%) |
| Diabetes (Type II) | 4 (40.0%) | 2 (33.3%) |
| Obesity | 7 (70.0%) | 5 (83.3%) |
| Active | 0 (0.0%) | 0 (0.0%) |
| Previous | 2 (20.0%) | 1 (16.7%) |
| Chronic liver disease | 0 (0.0%) | 0 (0.0%) |
| Chronic kidney disease | 0 (0.0%) | 0 (0.0%) |
Mean ± SD (minimum, maximum) or n (%).
BMI, body mass index; KL, Kellgren-Lawrence grade; KOOS, Knee Injury and Osteoarthritis Outcome Score.
Figure 1Differentially expressed genes in Low- and High-frequency tensile strain conditions (versus Control). (a) All differentially expressed genes and (b) differentially expressed coding genes. Each panel contains volcano plots displaying the top differentially expressed genes for low frequency cyclic tensile strain (vs control) and high frequency cyclic tensile strain (vs control). The Y-axis represents the − log10 p-value cut-off set at 1.3 (p-value < 0.05) and the X-axis represents the log2 fold change cut-off of below − 1.0 (blue) or above 1.0 (red). Venn diagrams display the number of differentially expressed genes in common and unique to Low and High-frequency tensile strain conditions.
Top 10 Enriched Hallmark gene sets for low and high frequency tensile strain.
| HALLMARK: low-frequency strain versus control | ||
|---|---|---|
| Gene set | NES | FDR q-val |
| Interferon gamma response | 4.18 | < 0.0001 |
| Interferon alpha response | 4.00 | < 0.0001 |
| Protein secretion | 3.62 | < 0.0001 |
| Oxidative phosphorylation | 3.49 | < 0.0001 |
| Allograft rejection | 3.27 | < 0.0001 |
| TNF-α signaling via NFκB | 3.19 | < 0.0001 |
| Apoptosis | 3.09 | < 0.0001 |
| Inflammatory response | 3.02 | < 0.0001 |
| Adipogenesis | 2.93 | < 0.0001 |
| Hypoxia | 2.82 | < 0.0001 |
FDR, false discovery rate; NES, normalized enrichment score.
Metabolism-related Gene sets from Reactome exclusively enriched following high-frequency tensile strain.
| REACTOME: exclusive to high-frequency strain | ||
|---|---|---|
| Gene set | NES | FDR q-value |
| Glyoxylate metabolism and glycine degradation | 2.02 | 0.01 |
| Metabolic Disorders of biological oxidation enzymes | 2.00 | 0.01 |
| Cytochrome P450 Arranged by Substrate Type | 1.98 | 0.01 |
| Respiratory ETC ATP Synthesis by Chemiosmotic Coupling and Heat Production by Uncoupling Proteins | 1.83 | 0.03 |
| Macroautophagy | 1.82 | 0.03 |
| Fatty Acids | 1.76 | 0.03 |
| Citric Acid Cycle/TCA Cycle | 1.75 | 0.03 |
| ER Quality Control Compartment ERQC | 1.75 | 0.03 |
| Diseases of Metabolism | 1.73 | 0.04 |
| Endogenous Sterols | 1.69 | 0.04 |
FDR, false discovery rate; NES, normalized enrichment score.
Top Reactome leading edge genes related to cell stress, ROS, NOS, and cell metabolism gene sets enriched by low- or high-frequency (vs. control), or low- vs high-frequency tensile strain.
| Low vs control | High vs control | Low vs high | High vs low |
|---|---|---|---|
| UBC | CYC5 | RPS27A | CYP1A2 |
| UBB | SOD2 | UBB | CYP2A13 |
| GLB1 | FDXR | UBA52 | CYP4F22 |
| RPS27A | PRKAB2 | UBC | CYP2J2 |
| CTSA | FDX1 | DLD | UGT1A1 |
| UBA52 | FDX2 | SDHC | UGT1A4 |
| GYG1 | PRKAG2 | SDHD | |
| PRKAB2 | PGM2L1 | SDHA | |
| HEXB | DLD | MLST8 | |
| HEXA | PRKAA2 | ATP5F1B |
Figure 2Lactate and MCP-1 release into conditioned media from synovial tissue. (a) Dot plot displaying the individual lactate measures as well as the mean ± 95% CI of lactate for Control (black), Low (light blue), and High (dark blue) strain conditions. (b) Dot plot displaying the individual MCP-1 measures as well as the mean ± 95% CI of lactate for Control (black), Low (light blue), and High (dark blue) strain conditions. (c) Linear mixed effects model estimates for lactate (Model 1) and MCP-1 (Model 2) in conditioned media for each cyclic tensile strain condition. CI, confidence interval; nmol, nanomolar; pg/mL, picogram per millilitre.
Figure 3Cyclic tensile strain increases 3-NT staining in OA synovial tissue. (a) Representative immunofluorescence images of 3-NT (green) and CD68 (magenta) for each cyclic tensile strain loading condition. (b) Dot plots displaying the individual 3-NT + cells (mean ± 95% CI) for Control (black), Low (light blue), and High (dark blue) tensile strain conditions. Scale bar = 20 μm. 3-NT, 3-Nitrotyrosine; CD68, macrophage marker; CI, confidence interval; DAPI, nuclear stain.
Figure 4Synovial cyclic tensile strain experimental set up. (a) Representative image of synovial tissue sample loaded on CellScale BioTester apparatus. (b) Close up image of synovial tissue attached to Biorakes with strain displacement graph (red).